CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Drugs Made In America Acquisition II Corp.
Sign in to watch- Ticker
- DMII
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 954-870-3104
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMII Ordinary Shares Nasdaq
- DMIIR Right Nasdaq
- DMIIU Unit Nasdaq
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Other events
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
Page 1 of 1 · 12 filings